TRIM58 and breast cancer: Besides, it was found that TRIM58 interacts with DDX3 and negatively regulates the expression of DDX3, leading to ubiquitination degradation of DDX3 and thus increasing adriamycin resistance in breast cancer cells (Wang et al., 2022).